Hypermethylation at the PTCH1 promoter region has been described in rhabdomyosarcoma, medulloblastomas [20], and breast cancer [21,22], astrocytoma and medulloblastoma cell lines contributing to HH signaling activation [23,24]. Here, PTCH1 is linked to rhabdomyosarcoma.